US2007179099A1PendingUtilityA1

Methods of cholesterol reduction using isoflavones

Assignee: NOVOGEN RES PTY LTDPriority: May 19, 1992Filed: Jul 20, 2006Published: Aug 2, 2007
Est. expiryMay 19, 2012(expired)· nominal 20-yr term from priority
Inventors:Graham Kelly
A61K 36/48A61K 31/35A23L 33/11A23L 11/05A61K 31/7048A61K 31/353A23L 11/07A61P 7/00A61P 35/00A61P 3/06A61P 5/00A61P 3/00A61P 15/00A61P 15/12A61P 13/08A61P 13/02A61P 1/00
71
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This invention relates to supplements that can be used to prevent or ameliorate such conditions as breast cancer, benign breast disease, pre-menstrual syndrome, or symptoms associated with menopause in women, or various types of cancer, and especially for high blood cholesterol levels in all humans, for instance.

Claims

exact text as granted — not AI-modified
1 - 20 . (canceled)  
   
   
       21 . A method for treating or reducing the predisposition to elevated blood cholesterol, said method comprising administering to a subject having said condition or predisposed to said condition a therapeutically effective amount of a health supplement composition comprising an extract from soya or clover, said composition comprising any two or more phytoestrogens of the group Genistein, Daidzein, Biochanin A, Formononetin or the natural glycosides of any of said phyto-estrogens.  
   
   
       22 . The method according to  claim 21 , wherein said phytoestrogen is extracted from soy.  
   
   
       23 . The method according to  claim 22 , wherein said phytoestrogen is extracted from soy hypocotyls.  
   
   
       24 . A method according to  claim 21 , wherein said phytoestrogen consists essentially of a) genistein and b) daidzein component, wherein component a) optionally contains biochanin A, and component b) optionally contains formononetin, and the ratio of a):b) is about 1:2 to 2:1.  
   
   
       25 . The method according to  claim 21 , wherein the phytoestrogen is administered in an amount of from about 20 mg to 200 mg per day.  
   
   
       26 . The method according to  claim 21 , wherein the phytoestrogen is administered in an amount of from about 50 mg to 150 mg per day.  
   
   
       27 . The method according to  claim 21  whereby the phytoestrogen is administered at least daily, over a period of at least a month.

Join the waitlist — get patent alerts

Track US2007179099A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.